Roche

Jason W. Roche

Associate
Boston

I work with innovative companies during their most critical stages – formation, scaling and exit.

Jason Roche’s practice focuses on working with emerging technology and life science companies throughout the corporate life cycle, including on early-stage formation and structuring matters, angel and venture financings, commercial transactions, mergers and acquisitions, and general corporate governance matters.

Education

  • Boston University School of Law, J.D., magna cum laude, 2017
  • University of Massachusetts, Amherst, B.A., magna cum laude, 2014

Bar and Court Admissions

BAR ADMISSIONS
  • Massachusetts

Experience

  • Cultivate Holdings in its sale to Cresco Labs (CSE:CL) (OTCQX:CRLBF), for upfront consideration equal to $90 million plus an earnout of up to $68 million.
  • Venture capital firm Bessemer Venture Partners as lead investor in a $17 million funding round for money management platform Truebill
  • Global cannabis operator Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) in its $69 million acquisition of Project Cannabis, a leading cannabis cultivator, wholesaler and retailer 
  • Rental platform Zumper in a $60 million Series D round led by e.ventures, and its previous $46 million Series C financing led by Axel Springer and Stereo Capital, with participation from Blackstone and existing investors Dawn Capital, Kleiner Perkins, Breyer Capital, Scott Cook, Goodwater Capital and xfund
  • OnShape, creators of the first Software as a Service (SaaS) product development platform that unites robust computer aided design (CAD) with powerful data management and collaboration tools, in signing a definitive agreement to sell the business to global technology company PTC Inc. for approximately $470 million
  • Rammer.AI in a $1.8 million seed round 
  • Morphic Therapeutic in its $80 million Series B financing
  • Inovalon Holdings Inc. (Nasdaq: INOV) in its $1.2B acquisition of ABILITY Network
  • Vasta Global, a provider of software solutions for clinical research and bioinformatics needs, in the sale of all of its outstanding equity to OMH-HealthEdge Holdings
  • Pointillist, developer of a customer journey analytics software intended to rapidly uncover customer insights and improve customer experience, in its sale to Genesys
  • Certica Solutions, an edtech platform-as-a-service (PaaS) company, in its acquisition of TE21
  • Satellite Biosciences, a developer of first-in-class, implantable satellite organs as living therapeutic solutions for serious diseases, in their $110 million Series A and Series Seed financings
  • AeroSafe Global, a developer of aerogels used in various transport, biomedical, pharmaceutical and other temperature sensitive products, in their Series D and Series E financings
  • NeoNet Capital in the $20 million Series B Financing of MarvelBiome, a biopharmaceutical company using microbes for treating diseases, led by other investors including Drads Capital
  • SeLux Diagnostics, a developer of a next generation phenotyping platform (NGP), in its $25 million Series B financing led by Sands Capital Ventures

Publications